imatinib mesylate has been researched along with Right Ventricular Dysfunction in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barst, RJ; Campbell, P; Peacock, A; Quinn, D; Rocha, GQ; Shah, AM; Solomon, SD | 1 |
| Campbell, P; Claggett, B; Querejeta Roca, G; Quinn, D; Shah, AM; Solomon, SD; Vazir, A | 1 |
| Behr, J; Borst, MM; Ewert, R; Ghofrani, HA; Grünig, E; Halank, M; Hoeper, MM; Klose, H; Lange, TJ; Olschewski, H; Opitz, C; Rosenkranz, S; Seeger, W; Speich, R; Ulrich, S; Welte, T; Wilkens, H | 1 |
| Bovenschulte, H; Dumitrescu, D; Erdmann, E; Rosenkranz, S; ten Freyhaus, H | 1 |
1 review(s) available for imatinib mesylate and Right Ventricular Dysfunction
| Article | Year |
|---|---|
[Imatinib for pulmonary arterial hypertension].
Topics: Benzamides; Germany; Humans; Hypertension, Pulmonary; Imatinib Mesylate; Off-Label Use; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Randomized Controlled Trials as Topic; Survival Rate; Ventricular Dysfunction, Right | 2014 |
2 trial(s) available for imatinib mesylate and Right Ventricular Dysfunction
| Article | Year |
|---|---|
Effect of imatinib as add-on therapy on echocardiographic measures of right ventricular function in patients with significant pulmonary arterial hypertension.
Topics: Analysis of Variance; Antihypertensive Agents; Blood Flow Velocity; Blood Pressure; Echocardiography, Doppler; Exercise Tolerance; Female; Humans; Hypertension, Pulmonary; Hypertrophy, Left Ventricular; Imatinib Mesylate; Male; Middle Aged; Observer Variation; Stroke Volume; Tricuspid Valve Insufficiency; Vascular Resistance; Ventricular Dysfunction, Right | 2015 |
Impact of lowering pulmonary vascular resistance on right and left ventricular deformation in pulmonary arterial hypertension.
Topics: Adult; Benzamides; Female; Humans; Hypertension, Pulmonary; Imatinib Mesylate; Male; Middle Aged; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Treatment Outcome; Ultrasonography; Vascular Resistance; Ventricular Dysfunction, Left; Ventricular Dysfunction, Right | 2015 |
1 other study(ies) available for imatinib mesylate and Right Ventricular Dysfunction
| Article | Year |
|---|---|
Significant improvement of right ventricular function by imatinib mesylate in scleroderma-associated pulmonary arterial hypertension.
Topics: Animals; Benzamides; Female; Humans; Hypertension, Pulmonary; Imatinib Mesylate; Middle Aged; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Scleroderma, Systemic; Treatment Outcome; Ventricular Dysfunction, Right | 2009 |